This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
6-APB: Difference between revisions
>Dextromethorphan No edit summary |
>Dextromethorphan |
||
| Line 136: | Line 136: | ||
*'''Canada:''' 6-APB is Schedule III in Canada as it is an analogue of MDA. The CDSA was updated as a result of the Safe Streets Act changing amphetamines from Schedule 3 to Schedule 1. | *'''Canada:''' 6-APB is Schedule III in Canada as it is an analogue of MDA. The CDSA was updated as a result of the Safe Streets Act changing amphetamines from Schedule 3 to Schedule 1. | ||
*'''UK:''' On June 10, 2013 6-APB and a number of analogues were classified as Temporary Class Drugs in the UK following an ACMD recommendation. On March 5, 2014 the UK Home Office announced that 6-APB would be made a class B drug on 10 June 2014 alongside every other benzofuran entactogen and many structurally related drugs<ref>http://www.legislation.gov.uk/uksi/2014/1106/contents/made</ref> | *'''UK:''' On June 10, 2013 6-APB and a number of analogues were classified as Temporary Class Drugs in the UK following an ACMD recommendation. On March 5, 2014 the UK Home Office announced that 6-APB would be made a class B drug on 10 June 2014 alongside every other benzofuran entactogen and many structurally related drugs<ref>http://www.legislation.gov.uk/uksi/2014/1106/contents/made</ref> | ||
*'''USA:''' 6-APB is unscheduled in the United States, but not currently approved by the Food and Drug Administration for human consumption. | *'''USA:''' 6-APB is unscheduled in the United States, but not currently approved by the Food and Drug Administration for human consumption. | ||